Insight Molecular Diagnostics (IMDX) EBIT Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) EBIT Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -130.92% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 8.57% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 14.55% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 33.00% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 3.63% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -18.11% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 27.44% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 2.57% |
| 10 | Insight Molecular Diagnostics | 4.34 Mn | -24.59 Mn | 15,000.00 | 35.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.09% |
| Dec 31, 2025 | 16.81% |
| Sep 30, 2025 | 18.25% |
| Jun 30, 2025 | -112.48% |
| Mar 31, 2025 | 26.63% |
| Dec 31, 2024 | 190.70% |
| Sep 30, 2024 | -107.51% |
| Jun 30, 2024 | 44.15% |
| Mar 31, 2024 | -258.41% |
| Dec 31, 2023 | -38.90% |
| Sep 30, 2023 | -281.77% |
| Jun 30, 2023 | -410.09% |
| Mar 31, 2023 | 293.90% |
| Dec 31, 2022 | 67.35% |
| Sep 30, 2022 | 87.46% |
| Jun 30, 2022 | 88.02% |
| Mar 31, 2022 | 73.44% |
| Dec 31, 2021 | -469.33% |
| Sep 30, 2021 | -117.87% |
| Jun 30, 2021 | -54.74% |